Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine
2006

Tat Oyi Vaccine Shows Promise Against HIV-1

Sample size: 7 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jennifer D Watkins, Sophie Lancelot, Grant R Campbell, Didier Esquieu, Jean de Mareuil, Sandrine Opi, Sylvie Annappa, Jean-Pierre Salles, Erwann P Loret

Primary Institution: UMR Univ. Med./CNRS FRE 2737, Faculté de Pharmacie, Université de la Méditerranée

Hypothesis

Can a synthetic vaccine based on the HIV-1 Tat protein effectively eliminate reservoir cells in macaques?

Conclusion

The Tat Oyi vaccine appears to effectively eliminate reservoir cells and control viremia in vaccinated macaques.

Supporting Evidence

  • Five out of seven vaccinated macaques showed better control of viremia compared to controls.
  • Reservoir cells were not detectable at 56 days post-challenge in all Tat Oyi vaccinated macaques.
  • No toxicity was observed in rabbits and macaques during the study.

Takeaway

Scientists created a new vaccine that helps fight HIV by making it so the virus can't hide in the body anymore.

Methodology

The study involved immunizing rabbits and macaques with the Tat Oyi vaccine and then challenging them with SHIV to assess the immune response and control of viremia.

Limitations

The study was conducted on a small sample size of macaques, and results may not fully translate to humans.

Participant Demographics

Rabbits and Rhesus macaques were used in the study.

Statistical Information

P-Value

0.009

Statistical Significance

p = 0.009

Digital Object Identifier (DOI)

10.1186/1742-4690-3-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication